Alabama researcher will succeed Fauci in infectious disease post
A research scientist at the University of Alabama at Birmingham has been named to succeed Dr. Anthony Fauci as the nation’s top infectious disease expert
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A research scientist at the University of Alabama at Birmingham was named Wednesday to succeed Dr. Anthony Fauci as the nation’s top infectious disease expert. Dr. Jeanne Marrazzo will become director of the National Institute of Allergy and Infectious Diseases in the fall. She will oversee the agency's $6.3 billion budget, its research and its response to infectious disease outbreaks.
Fauci, 82, retired from a five-decade career in December. During the COVID-19 pandemic, he became a household name as he gave updates at daily White House press conferences and in frequent media interviews.
Since Fauci's retirement, Dr. Hugh Auchincloss Jr. has been serving as acting director.
Marrazzo's research has focused on sexually transmitted diseases and the prevention of HIV infection. At the university, she is director of the medical school's division of infectious diseases.
Her appointment was made by Lawrence Tabak, acting director for the National Institutes of Health.